Compare GNTX & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GNTX | GRFS |
|---|---|---|
| Founded | 1974 | 1940 |
| Country | United States | Spain |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 6.2B |
| IPO Year | N/A | 2006 |
| Metric | GNTX | GRFS |
|---|---|---|
| Price | $24.12 | $9.28 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 2 |
| Target Price | ★ $28.33 | $10.15 |
| AVG Volume (30 Days) | ★ 2.9M | 469.7K |
| Earning Date | 01-30-2026 | 07-28-2022 |
| Dividend Yield | ★ 1.96% | 1.55% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.74 | 0.64 |
| Revenue | $2,534,268,965.00 | ★ $8,821,017,248.00 |
| Revenue This Year | $7.37 | $5.36 |
| Revenue Next Year | $5.07 | $5.15 |
| P/E Ratio | ★ $14.07 | $17.79 |
| Revenue Growth | ★ 9.55 | 7.31 |
| 52 Week Low | $20.28 | $6.19 |
| 52 Week High | $29.38 | $11.14 |
| Indicator | GNTX | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 55.23 | 48.88 |
| Support Level | $22.31 | $9.23 |
| Resistance Level | $25.14 | $9.60 |
| Average True Range (ATR) | 0.63 | 0.19 |
| MACD | 0.08 | 0.00 |
| Stochastic Oscillator | 73.14 | 53.61 |
Gentex was founded in 1974 to produce smoke-detection equipment. The company sold its first glare-control interior mirror in 1982 and its first model using electrochromic technology in 1987. Automotive revenue is about 98% of total revenue. The company is constantly developing new applications for the technology to remain on top. Sales in 2024 totaled about $2.3 billion with 47.7 million mirrors shipped. The unit mix breaks out as 63% interior and 37% exterior, versus 31% exterior in 2019. The company is based in Zeeland, Michigan.
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.